Brief: Hansa Biopharma Says To Issue 10.5 Million New Ordinary Shares At SEK 22.00 Each
19/06/2025 24:25
June 18 (Reuters) - Hansa Biopharma AB HNSA.ST: HANSA BIOPHARMA HAS CARRIED OUT A DIRECTED CASH SHARE ISSUE OF APPROX. MSEK 232 AND ENTERED INTO BINDING AGREEMENT TO RESTRUCTURE DEBT HELD BY NOVAQUEST, INCLUDING SET-OFF ISSUE OF USD 14.9 MILLION HANSA BIOPHARMA AB - TO ISSUE 10,550,000 NEW ORDINARY SHARES AT SEK 22.00 EACH Source text: ID:nWkr9RlwBz Further company coverage: HNSA.ST ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hansa Biopharma AB
See all newsBrief: Hansa Biopharma Q3 Rev Up At SEK 143 Mln
Sweden's Hansa Biopharma Q3 revenue surges on SERB license deal
Brief: Hansa Biopharma Q3 Net Income SEK -178.5 Million
Brief: Hansa Biopharma Announces Positive Idefirix Paes Results Presented In The High-Impact Clinical Trials Session At Asn Kidney Week
Brief: Hansa Biopharma Submits IND Application To FDA For HNSA-5487 In GBS